Difference between revisions of "Leadership"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
[unchecked revision][unchecked revision]
Line 3: Line 3:
  
 
[[File:Fabiola-Quintero Riviera-orig 2019.jpg|center|thumb|Fabiola-Quintero-Rivera, PhD, Professor, Department of Pathology and Laboratory Medicine, University of California Los Angeles; '''Associate Editor CCGA [MDS/MPN Section]''']]
 
[[File:Fabiola-Quintero Riviera-orig 2019.jpg|center|thumb|Fabiola-Quintero-Rivera, PhD, Professor, Department of Pathology and Laboratory Medicine, University of California Los Angeles; '''Associate Editor CCGA [MDS/MPN Section]''']]
 +
 +
[[File:Yassmine Akkari.png|center|thumb|FYassmine Akkari, PhD, FACMG, cientific Director, Cytogenetics and Molecular Pathology, Manager, Genetics Laboratories Operations, Legacy Health; '''Associate Editor CCGA [ALL Section]''']]
  
 
[[File:Snehal Patel1.jpg|center|thumb|Snehal Patel, MD, PhD; '''Co-Associate Editor CCGA [Lymphoma Section]''']]
 
[[File:Snehal Patel1.jpg|center|thumb|Snehal Patel, MD, PhD; '''Co-Associate Editor CCGA [Lymphoma Section]''']]

Revision as of 10:49, 13 May 2020

Jennelle C. Hodge, PhD, Associate Professor, Department of Medical and Molecular Genetics, Indiana University; Acting Editor-in-Chief CCGA, Associate Editor [AML Section]
Fabiola-Quintero-Rivera, PhD, Professor, Department of Pathology and Laboratory Medicine, University of California Los Angeles; Associate Editor CCGA [MDS/MPN Section]
FYassmine Akkari, PhD, FACMG, cientific Director, Cytogenetics and Molecular Pathology, Manager, Genetics Laboratories Operations, Legacy Health; Associate Editor CCGA [ALL Section]
Snehal Patel, MD, PhD; Co-Associate Editor CCGA [Lymphoma Section]